Where science, technology
and translation converge
Our formula to develop trailblazing drugs and advance health sciences is based on extreme collaboration between three hubs: ambitious scientific research, ever-evolving technological innovation and a constant translational effort of carrying our breakthroughs from bench to bedside.
We alleviate the societal burden of complex human diseases by engaging in continuous innovation that integrates chemistry, biology and pharmaceutical sciences. Multidisciplinary teams collaborate daily to develop pioneering tools and techniques to prevent, detect and treat cancer, neurodegenerative, metabolic and infectious diseases.
We are highly engaged in translating our advanced scientific knowledge and technologies into breakthrough healthcare solutions that empower societies to live better and healthier. A vibrant network based on strong partnerships between our scientific community, distinct players within pharmaceutical and biotechnology companies and the Healthcare sector transforms innovative research & technologies into useful everyday products and life-saving medicines.
We are deeply committed to move pharmacological research into the patient's context by developing disruptive translational innovations to benefit human health, by converging our fundamental science discoveries into applied research. This is driven by the joint efforts of our institute with multiple players within the Healthcare sector (including international health policy-makers and clinicians) as well as the permanent dialog with professional and patient associations.